Loratadine Patent Expiration

Loratadine was first introduced by Bayer Healthcare Llc in its drug Claritin on Nov 27, 2002. Other drugs containing Loratadine are Alavert, Claritin Reditabs, Claritin Hives Relief, Claritin Hives Relief Reditab, Loratadine, Children'S Claritin. 31 different companies have introduced drugs containing Loratadine.


Loratadine Patents

Given below is the list of patents protecting Loratadine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Claritin US6132758 Stabilized antihistamine syrup Jun 01, 2018

(Expired)

Bayer Healthcare Llc



Loratadine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Loratadine Generic API Manufacturers

Several generic applications have been filed for Loratadine. The first generic version for Loratadine was by Pld Acquisitions Llc and was approved on Jan 21, 2003. And the latest generic version is by Sun Pharmaceutical Industries Ltd and was approved on Apr 25, 2025.

Given below is the list of companies who have filed for Loratadine generic, along with the locations of their manufacturing plants worldwide.